XT
MAIA icon

XTX Topco’s MAIA Biotechnology MAIA Stock Holding History

XTX Topco’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,991
Closed -$30.9K – 2675
2024
Q3 		$30.9K Buy
+10,991
New +$34.3K ﹤0.01% 1772
2024
Q1 		– Sell
-23,965
Closed -$28K – 2128
2023
Q4 		$28K Buy
+23,965
New +$38.7K 0.01% 1321

Other funds holding MAIA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFF
Halter Ferguson Financial Carmel, Indiana $456M AUM 49.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

XTX Topco's MAIA Position: Q4 2024 in Review

XTX Topco sold out of MAIA Biotechnology (MAIA) in Q4 2024, closing a stake of 10,991 shares — an estimated $30.9K sold.

XTX Topco first reported a position in MAIA in Q4 2023 and held it in 2 quarters. The position peaked at $30.9K in Q3 2024. 20 funds tracked by Wall St. Rank hold MAIA as of Q4 2024.

  • XTX Topco reported no remaining MAIA Biotechnology position as of Q4 2024 after selling out during the quarter.
  • XTX Topco sold 10,991 MAIA Biotechnology shares in Q4 2024, an estimated $30.9K.
  • XTX Topco first reported a position in MAIA Biotechnology in Q4 2023 and held it in 2 quarters.
  • XTX Topco's MAIA Biotechnology position peaked at $30.9K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q4 2024.

Based on XTX Topco's 13F filing for Q4 2024, filed 13 Feb 2025.